Objective: To determine the correlation of serum dehydroepiandrosterone sulphate and anti-mullerian hormone levels with infertility in females.
Study Design: Cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology, the Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from July 2022 to August 2023.
Methodology: About 110 infertile females with infertility were enrolled in this study. Serum thyroid-stimulating hormone, luteinising hormone, testosterone, follicle-stimulating hormone (FSH), estradiol, serum Anti-Mullerian Hormone (AMH), and Dehydroepiandrosterone Sulphate (DHEA-S) were measured at 3rd menstruation day. Females with primary ovarian insufficiency, using androgen supplementation, and on hormonal therapy were excluded.
Results: Among the participants, 63.6% had primary infertility and 36.4% had secondary infertility. Both primary and secondary infertility had a positive correlation with serum AMH and DHEA-S levels (r = 0.685; p <0.001) and (r = 0.807; p <0.001), respectively. After ultrasound, 54 (49.1%) females were normal, 12 (10.9%) had PCOS, 12 (10.9%) had fibroids, 8 (7.3%) had fallopian tube defects, 10 (9.1%) had endometriosis, and 14 (12.7%) had low antral follicular count. The correlation between serum AMH and DHEA-S with different subgroups is as follows: Normal females (r = 0.731; p <0.001), PCOs (r = -0.232; p = 0.468), fibroids (r = 0.941, p <0.001), fallopian tube defects (r =-0.800; p = 0.017), endometriosis (r = -0.684, p = 0.013), and low antral follicular count (r = 0.643, p = 0.0130).
Conclusion: This study demonstrated a positive correlation between serum AMH and DHEA-S levels in infertile females.
Key Words: Infertile women, Ovarian reserve, Anti-Mullerian Hormone, Dehydroepiandrosterone sulphate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.29271/jcpsp.2025.02.157 | DOI Listing |
BMC Med
March 2025
Monash Centre for Health Research and Implementation, School of Clinical Sciences, Monash University, Clayton, VIC, 3168, Australia.
Background: During adolescence, accurate diagnostic criteria and/or identification of adolescents "at risk" of polycystic ovary syndrome (PCOS) are critical to establish appropriate screening, treatment, and lifelong health plans. The 2023 International Evidence-Based Guideline for PCOS aimed to provide the most up-to-date evidence-based recommendations to improve health outcomes for individuals with PCOS, emphasizing accurate and timely diagnosis of PCOS from adolescence.
Methods: The best practice methods following the Appraisal of Guidelines for Research and Evaluation (AGREE-II) criteria were applied.
Zhen Ci Yan Jiu
February 2025
Second Clinical College, Shanxi University of Chinese Medicine, Jinzhong 030600, Shanxi Province, China.
Objectives: To observe the effect of penetrative needling of "Zhibian" (BL54) through "Shuidao" (ST28) on the expressions of internal and external apoptosis-related factors in mice with poor ovarian response (POR), so as to explore its mechanisms underlying improvement of POR.
Methods: Sixty-nine female C57BL/6N mice were randomly divided into blank, model and acupuncture groups (=23 in each group). The POR model was established by gavage of tripterygium wilfordii polyglucoside suspension (50 mg·kg).
BMC Womens Health
March 2025
SKIMS, Srinagar, India.
Objective: To study the cardiometabolic markers in women in with polycystic ovary syndrome (PCOS) across all phenotypes and its correlation with serum anti-mullerian hormone (AMH) levels.
Methodology: In cross-sectional community-based study aimed to determine the prevalence of PCOS among women aged 19-39 years over 5 years (2018-2022), 10,109 women were found to be eligible from 14,061 approached through a pre validated questionnaire. Out of this cohort, 201 women were diagnosed prior, and from the 2314 probable cases on detailed clinical, ultrasound and hormonal evaluation as per Rotterdam criteria, 860 were true cases.
J Dairy Sci
March 2025
Department of Animal Sciences and Industry, Kansas State University, Manhattan, KS, USA, 66506. Electronic address:
The aim of this cross-sectional observational study was to assess whether nulliparous Holstein heifer fertility is associated with (1) energy reserve-related traits, such as body condition score (BCS) and body weight (BW); (2) ovarian reserve-related traits, such as Anti-Müllerian hormone (AMH) and antral follicle count (AFC); and (3) development-related traits, such as anogenital distance (AGD) and vulval length (VUL). From August 2022 through July 2023, we used a prospective approach in which the phenotypic traits (BCS, AMH, AFC, AGD, BW, and VUL) of 698 Holstein heifers were measured once at approximately 12 mo of age (at the beginning of the breeding program). All heifers were submitted to the herd reproductive management from 367 ± 3 d of age and 297 kg of BW until 570 d of age, or 5 breedings.
View Article and Find Full Text PDFFree Radic Biol Med
March 2025
Department of Histology,Embryology, Genetics and Developmental Biology, Shanghai Key Laboratory for Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address:
Premature ovarian insufficiency (POI) is characterized by follicular development failure or follicular dysplasia, therefore causing the lack of normal ovarian function before 40 years of age. Trimethylamine N-oxide (TMAO) is a metabolite of high choline diet rich in red meat and directly associated with gut microbiota. Correlation of TMAO level with female fertility decline has been shown; however, its mechanism is largely unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!